Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Ikeda
Ken
K
Araki
Yo
Y
Iwasaki
Yasuo
Y
D001323:Autoantibodies / Q000032:analysis* / Q000097:blood / Q000276:immunology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000276:immunology / Q000601:surgery; D009188:Myelitis, Transverse / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D009902:Optic Neuritis / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology; D011237:Predictive Value of Tests; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D013934:Thymectomy / Q000009:adverse effects
D001323:Autoantibodies